{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:22:13Z","timestamp":1791303733016,"version":"4.1.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1784,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Neuropole de Recherche Francilien (NeRF)"},{"DOI":"10.13039\/100005725","name":"CHDI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbadis.2009.07.012","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T06:01:50Z","timestamp":1250056910000},"page":"52-61","source":"Crossref","is-referenced-by-count":252,"title":["Mitochondria in Huntington's disease"],"prefix":"10.1016","volume":"1802","author":[{"given":"Maria","family":"Damiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"D\u00e9glon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Brouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2009.07.012_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.07.012_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.07.012_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(03)00116-8","article-title":"Mitochondria: releasing power for life and unleashing the machineries of death","volume":"112","author":"Newmeyer","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2009.07.012_bib6","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1089\/ars.2006.8.1997","article-title":"Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders","volume":"8","author":"Mattson","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2009.07.012_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib10","series-title":"Huntington's disease","author":"Harper","year":"1991"},{"key":"10.1016\/j.bbadis.2009.07.012_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.07.012_bib13","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2009.07.012_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1590\/S0100-879X2006000800016","article-title":"Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat","volume":"39","author":"Ruocco","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbadis.2009.07.012_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2009.07.012_bib16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.07.012_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington's disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur. J. NeuroSci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","article-title":"Clinical and neuropathologic assessment of severity in Huntington's disease","volume":"38","author":"Myers","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.07.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.07.012_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbadis.2009.07.012_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib24","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pages","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1385\/MN:28:3:259","article-title":"Wild-type huntingtin plays a role in brain development and neuronal survival","volume":"28","author":"Reiner","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib28","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib29","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib30","doi-asserted-by":"crossref","first-page":"39594","DOI":"10.1074\/jbc.C200353200","article-title":"Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons","volume":"277","author":"Goffredo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib31","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","article-title":"Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.07.012_bib32","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003","article-title":"Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease","volume":"23","author":"Bizat","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib33","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.mad.2006.01.022","article-title":"Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease","volume":"127","author":"Lee","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbadis.2009.07.012_bib36","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0197-0186(01)00059-6","article-title":"Does tissue transglutaminase play a role in Huntington's disease?","volume":"40","author":"Lesort","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2009.07.012_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin\u2013protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1100\/tsw.2008.60","article-title":"The ubiquitin\u2013proteasome pathway in Huntington's disease","volume":"8","author":"Finkbeiner","year":"2008","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bbadis.2009.07.012_bib43","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00018-007-7222-8","article-title":"Is the ubiquitin\u2013proteasome system impaired in Huntington's disease?","volume":"64","author":"Ortega","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4161\/auto.2696","article-title":"Protective roles for induction of autophagy in multiple proteinopathies","volume":"2","author":"Menzies","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2009.07.012_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib46","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1517\/13543784.16.12.1933","article-title":"Huntington's disease: progress and potential in the field","volume":"16","author":"Stack","year":"2007","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbadis.2009.07.012_bib47","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2009.07.012_bib48","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib51","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00585-4","article-title":"In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease","volume":"410","author":"Panov","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2009.07.012_bib53","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib54","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archneur.64.6.890","article-title":"A MELAS-associated ND1 mutation causing leber hereditary optic neuropathy and spastic dystonia","volume":"64","author":"Spruijt","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajmg.a.31565","article-title":"A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia","volume":"143","author":"Sarzi","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(88)90124-4","article-title":"Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia","volume":"84","author":"Martin","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1095-144","article-title":"Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency","volume":"11","author":"Bourgeron","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib58","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajhg.2008.03.020","article-title":"Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ","volume":"82","author":"Barel","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib59","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/hmg\/ddn441","article-title":"Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence","volume":"18","author":"Ghezzi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib60","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib61","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","article-title":"Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases","volume":"67","author":"Butterworth","year":"1985","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib64","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington's disease","volume":"336","author":"Mann","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.07.012_bib65","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/exnr.2000.7626","article-title":"Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production","volume":"169","author":"Guidetti","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib67","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2009.07.012_bib68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib69","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/hmg\/ddm057","article-title":"Hsp27 overexpression in the R6\/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation","volume":"16","author":"Zourlidou","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib70","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbadis.2009.07.012_bib71","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2009.07.012_bib72","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.07.012_bib73","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.07.012_bib74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib76","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.07.012_bib77","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib78","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","article-title":"Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway","volume":"13","author":"Ruan","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2009.07.012_bib81","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib82","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/nm1067","article-title":"Molecular pathways to neurodegeneration","volume":"10 Suppl","author":"Bossy-Wetzel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.07.012_bib83","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib84","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib85","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/WNL.45.12.2178","article-title":"Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)","volume":"45","author":"He","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.07.012_bib86","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib87","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib88","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib89","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.07.012_bib90","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","article-title":"Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism","volume":"3","author":"Lee","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib91","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(99)01749-4","article-title":"Progress in understanding structure\u2013function relationships in respiratory chain complex II","volume":"466","author":"Ackrell","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2009.07.012_bib93","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ejhg.5200793","article-title":"Succinate dehydrogenase and human diseases: new insights into a well-known enzyme","volume":"10","author":"Rustin","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib94","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbadis.2009.07.012_bib95","unstructured":"E. Brouillet, E. Diguet, J. Garc\u00eda-Mart\u00ednez, Y. Trioulier, T. Delzescaux, A. Benchoua, F. Petit, C. Malgorn, N. Dufour, P. Hantraye, J. Canals, J. Alberch and N. D\u00e9glon, Short N-terminal fragment of mutant huntingtin produces an early loss of mitochondrial complex II in vivo, (2008)."},{"key":"10.1016\/j.bbadis.2009.07.012_bib96","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib97","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10571-007-9220-7","article-title":"Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range","volume":"27","author":"Majumder","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib98","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/hmg\/ddl248","article-title":"Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III","volume":"15","author":"Solans","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib99","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","article-title":"Mutant huntingtin and mitochondrial dysfunction","volume":"31","author":"Bossy-Wetzel","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib100","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib101","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.07.012_bib102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib103","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib104","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","article-title":"Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice","volume":"101","author":"Oliveira","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1119(01)00809-5","article-title":"Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells","volume":"286","author":"Scarpulla","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.bbadis.2009.07.012_bib107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9258(17)42320-9","article-title":"Differential regulation of respiratory chain subunits by a CREB-dependent signal transduction pathway. Role of cyclic AMP in cytochrome c and COXIV gene expression","volume":"269","author":"Gopalakrishnan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib108","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.0502878102","article-title":"Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons","volume":"102","author":"Ryu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.07.012_bib109","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.2004.02873.x","article-title":"Calcium-dependent dephosphorylation of brain mitochondrial calcium\/cAMP response element binding protein","volume":"92","author":"Schuh","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib111","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.07.012_bib113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcb.20743","article-title":"Nuclear control of respiratory gene expression in mammalian cells","volume":"97","author":"Scarpulla","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib114","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional paradigms in mammalian mitochondrial biogenesis and function","volume":"88","author":"Scarpulla","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2009.07.012_bib115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s004390051033","article-title":"Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome","volume":"106","author":"Parfait","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib116","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib117","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","article-title":"Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II","volume":"17","author":"Benchoua","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib118","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1073\/pnas.93.10.4925","article-title":"Translational regulation of mammalian and Drosophila citric acid cycle enzymes via iron-responsive elements","volume":"93","author":"Gray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.07.012_bib119","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","article-title":"Inositol 1, 4, 5-tripshosphate receptor, calcium signalling and Huntington's disease","volume":"45","author":"Bezprozvanny","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(94)90132-5","article-title":"Huntington's disease, energy, and excitotoxicity","volume":"15","author":"Beal","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2009.07.012_bib121","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/iub.91","article-title":"Calcium ions in neuronal degeneration","volume":"60","author":"Wojda","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2009.07.012_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2009.07.012_bib123","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib124","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-d-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib125","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib127","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2009.07.012_bib128","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib129","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib130","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib131","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib132","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0301-0082(96)00006-8","article-title":"Bioenergetics and glutamate excitotoxicity","volume":"48","author":"Greene","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib133","first-page":"223","article-title":"3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons","volume":"248","author":"Weller","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib134","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0306-4522(97)00389-8","article-title":"3-Nitropropionic acid exacerbates N-methyl-d-aspartate toxicity in striatal culture by multiple mechanisms","volume":"84","author":"Greene","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2009.07.012_bib135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0197-0186(02)00229-2","article-title":"Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid","volume":"43","author":"Nasr","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2009.07.012_bib136","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1046\/j.1471-4159.1995.64052332.x","article-title":"Exacerbation of NMDA, AMPA, and l-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate","volume":"64","author":"Greene","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib137","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1096\/fj.05-5085fje","article-title":"Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation","volume":"20","author":"Jacquard","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2009.07.012_bib138","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/exnr.1993.1071","article-title":"Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum","volume":"121","author":"Simpson","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib139","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1523\/JNEUROSCI.21-14-05110.2001","article-title":"Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine","volume":"21","author":"Calabresi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib140","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib141","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1474-4422(03)00411-3","article-title":"Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics","volume":"2","author":"Blum","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib142","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib143","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-2236(00)01568-X","article-title":"Neuronal cell death in Huntington's disease: a potential role for dopamine","volume":"23","author":"Jakel","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib144","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/hmg\/10.12.1243","article-title":"Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration","volume":"10","author":"Petersen","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.07.012_bib145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.mam.2006.08.008","article-title":"Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?","volume":"27","author":"Ravikumar","year":"2006","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bbadis.2009.07.012_bib146","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.07.012_bib147","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.07.012_bib148","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1096\/fj.06-6533fje","article-title":"Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin","volume":"20","author":"Cyr","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2009.07.012_bib149","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"27","author":"Tang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2007.07.028","article-title":"Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo","volume":"29","author":"Charvin","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.07.012_bib151","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib152","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.07.012_bib153","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2005.04.008","article-title":"The therapeutic role of creatine in Huntington's disease","volume":"108","author":"Ryu","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2009.07.012_bib154","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.07.012_bib155","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib156","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib157","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2032dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.07.012_bib158","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00001756-200307010-00015","article-title":"Ascorbate treatment attenuates the Huntington behavioral phenotype in mice","volume":"14","author":"Rebec","year":"2003","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbadis.2009.07.012_bib159","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1471-4159.2003.t01-1-01868.x","article-title":"Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease","volume":"86","author":"Klivenyi","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.07.012_bib160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1017\/S1092852900020538","article-title":"Coenzyme Q10: a review of its promise as a neuroprotectant","volume":"12","author":"Young","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbadis.2009.07.012_bib161","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.07.012_bib162","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T11:46:11Z","timestamp":1633779971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443909001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0925443909001653"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2009.07.012","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}